Clinical Trials

30 enrolled

Urinary Bladder Neoplasms

NCT00102544 2026-04-08

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

3,894 enrolled

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

NCT07205783 2026-04-07

Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)

40 enrolled

Prostatic Neoplasms

NCT02759744 2026-04-06

Fusion Guided Focal Laser Ablation of Prostate Cancer

30 enrolled

Phase 1 Enrolling by invitation

Prostatic Neoplasms

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

149 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT07488572 2026-03-23

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Phase 2 Enrolling by invitation

60 enrolled

Phase 1 Enrolling by invitation

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05700461 2026-03-20

Drug Screening Using Novel IMD in Renal Cell Carcinoma

20 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07474051 2026-03-16

PERSIST

GenitourinaryLymphoidOther hematologic neoplasm

178 enrolled

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05160480 2026-03-10

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

BreastEndocrineGenitourinaryNET

9 enrolled

Breast Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors

NCT07454941 2026-03-06

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

4,000 enrolled

Carcinoma, Transitional Cell, Disease

NCT06238661 2026-03-05

ProScreenMRI

4,500 enrolled

Prostatic Neoplasms

NCT05195515 2026-03-03

CONQUER

2,000 enrolled

Urinary Bladder Neoplasms

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

GastrointestinalGenitourinary

100 enrolled

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

120 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04254133 2026-01-30

GIFTS

1,360 enrolled

Prostatic Neoplasms

NCT06243510 2026-01-28

CARE

90 enrolled

Urinary Bladder Neoplasms

NCT05443321 2026-01-23

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

GastrointestinalGenitourinary

1,006 enrolled

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

NCT03181867 2026-01-21

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Phase 2 Enrolling by invitation

800 enrolled

Prostatic Neoplasms

NCT06472817 2026-01-21

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

80 enrolled

Phase 1/2 Enrolling by invitation

Prostatic Neoplasms

NCT05570994 2026-01-08

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

50 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT07307157 2025-12-29

COSMO

30 enrolled

CNSGenitourinaryThoracic

Brain Neoplasms, Disease, Kidney Neoplasms, Lung Neoplasms

NCT06604130 2025-11-28

exo-PRECISE

1,600 enrolled

Disease, Prostatic Neoplasms

NCT06935097 2025-11-10

Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer

25 enrolled

Prostatic Neoplasms

NCT03544983 2025-10-29

Genetic Education in BRCA Families

BreastGenitourinaryGynecologic

240 enrolled

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT07148765 2025-09-26

Use of Wearables Following Cystectomy- Part II

50 enrolled

Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic

NCT07180121 2025-09-18

CaRe

200 enrolled

Urinary Bladder Neoplasms

NCT06945640 2025-09-16

HTK_002

80 enrolled

Kidney Neoplasms

NCT03648359 2025-09-12

Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance

200 enrolled

Prostatic Neoplasms

NCT05739071 2025-09-11

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

100 enrolled

Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT06424275 2025-08-15

PRAISE-U

20,000 enrolled

Phase 2 Enrolling by invitation

Prostatic Neoplasms

NCT07101900 2025-08-08

68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

100 enrolled

Carcinoma, Renal Cell

NCT07112209 2025-08-08

Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer

20 enrolled

Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer

NCT07091565 2025-08-03

SPARC

60 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07082049 2025-07-24

AI-CAP

160 enrolled

Anxiety Disorders, Prostatic Neoplasms

NCT07075666 2025-07-20

Early Detection of Prostate Cancer of Syrian Men

1,000 enrolled

the Detection of Prostate Cancer in Men

NCT06885424 2025-07-15

DESCENT-1